Literature DB >> 23559596

Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta.

V Padovese1, A M Egidi, T Fenech Melillo, B Farrugia, P Carabot, D Didero, G Costanzo, C Mirisola.   

Abstract

BACKGROUND: In the last few years, Malta has witnessed increasing immigration flows from the Libyan coasts. Public health policies are focused on screening migrants for tuberculosis, whereas no systematic actions against STIs are implemented. The aim of this study is to define the epidemiological profile of asylum seekers in Malta as regards syphilis, hepatitis B, C and latent tuberculosis, thus supporting screening policies.
METHODS: Five hundred migrants living in open centres were screened between December 2010 and June 2011.
RESULTS: 83.2% of people was from Somalia, 81.2% males, average age 26.5 years. The tuberculin skin test (TST) was positive in 225 migrants (45%). Latent syphilis was diagnosed in 11 migrants, hepatitis C in 3 and 31 migrants were HBsAg positive.
CONCLUSION: Systematic screening for asymptomatic migrants in Malta is not recommended for hepatitis C and syphilis, given the low prevalence observed. On the contrary, it should be considered for hepatitis B. TST could be indicated as the first step of a two step screening for migrants from countries with high TB incidence. Efficacy and cost-effectiveness could be achieved by further targeting screening to specific subgroups at higher risk of reactivation, such as people living with HIV and subjects affected by chronic diseases.

Entities:  

Keywords:  Malta; hepatitis; migrants; sexually transmitted infections; tuberculosis

Mesh:

Year:  2013        PMID: 23559596     DOI: 10.1093/pubmed/fdt036

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  8 in total

Review 1.  A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.

Authors:  Jonathon R Campbell; Jane Krot; Kevin Elwood; Victoria Cook; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

Review 2.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

3.  Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis.

Authors:  Jonathon R Campbell; Wenjia Chen; James Johnston; Victoria Cook; Kevin Elwood; Jane Krot; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

4.  Is there a need of health assessments for resettling refugees? A cross-sectional study of 1431 refugees who arrived in Denmark between 2014 and 2018.

Authors:  Anne Mette F Hvass; Marie Norredam; Morten Sodemann; Christian Wejse
Journal:  J Migr Health       Date:  2021-04-21

5.  An Update on the Global Epidemiology of Syphilis.

Authors:  Noah Kojima; Jeffrey D Klausner
Journal:  Curr Epidemiol Rep       Date:  2018-02-19

Review 6.  Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study.

Authors:  Mohamed Abdulkadir Hassan-Kadle; Mugtaba Sulaiman Osman; Pavel Petrovich Ogurtsov
Journal:  World J Gastroenterol       Date:  2018-09-14       Impact factor: 5.742

7.  Prevalence and associated risk factors for Hepatitis B and C viruses among refugees in Gambella, Ethiopia.

Authors:  Abiyu Ayele; Dessie Abera; Melese Hailu; Muluken Birhanu; Kassu Desta
Journal:  BMC Public Health       Date:  2020-05-19       Impact factor: 3.295

8.  Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register.

Authors:  Paula Tiittala; Matti Ristola; Kirsi Liitsola; Jukka Ollgren; Päivikki Koponen; Heljä-Marja Surcel; Eija Hiltunen-Back; Irja Davidkin; Pia Kivelä
Journal:  BMC Infect Dis       Date:  2018-03-20       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.